Sulphasalazine alone or in combination with d-penicillamine in rheumatoid arthritis

Rheumatology

Volumn 26, Issue 1, 1987, Pages 32-36

  Taggart, A J ^a   Hill, J ^a   Astbury, C ^a   Dixon, J S ^a   Bird, H A ^a   Wright, V ^a  

^a Royal Bath Hospital   (United Kingdom)

Author keywords

Combination therapy; D Penicillamine; Rheumatoid arthritis; Sulphasalazine

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CHEMOTHERAPY; CLINICAL ARTICLE; DIGESTIVE SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG THERAPY; DYSGEUSIA; DYSPEPSIA; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; INTOXICATION; JOINT; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; RHEUMATOID ARTHRITIS; SKIN TOXICITY; THERAPY; THROMBOCYTOPENIA;

ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; PENICILLAMINE; SULFASALAZINE;

EID: 0023095515     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/26.1.32     Document Type: Article

References (25)

1. Harris EW. Rheumatoid arthritis: the clinical spectrum. In: Kelly WN, Harris EW, Ruddy S, Sledge CB, eds. Textbook of Rheumatology. Philadelphia: W B Saunders, 1981;918-63.
2. Ehrlich GE. Heroic treatment for non-malig nant disease [Editorial]. JAMA 1982;248: 1743-4.
3. Dixon JS. Biochemical and clinical changes in rheumatoid arthritis: their relation to the action of antirheumatoid drugs. Semin Arthritis Rheum 1982;12:191-207.
4. Evans DAP. An improved and simplified method of detecting the acetylator phenotype. J Med Genet 1969;6:405-7.
5. Pinals RS, Masi AT, Larsen RA, et al. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981; 24:1308-15.
6. Martin M, Dixon J, Hickling P, Bird H, Golding J, Wright V. A combination of d- penicillamine and hydroxychloroquine for the treatment of rheumatoid arthritis [Abstract], Ann Rheum Dis 1982;41:208.
7. Bunch TW, O’Duffy JD, Tompkins RB, O’Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984;27: 261-71.
8. Gibson T, Emery P, Armstrong R, Crisp A, Panayi G. Combined chloroquine and d- penicillamine in rheumatoid arthritis-better or worse? [Abstract]. Br,J Rheumatol 1986;25:114-5.
9. Bitter T. Combined disease-modifying chemo therapy for intractable rheumatoid arthritis. Clin Rheuni Dis 1984;10:417-28.
10. Bird HA, Dixon JS, Pickup ME, et al. A biochemical assessment of sulphasalazine in rheumatoid arthritis. J Rheumatol 1982;9: 36-45.
11. Pullar T, Capell HA. Sulphasalazine: a ‘new’ antirheumatic drug. Br J Rheumatol 1984; 23:26-34.
12. Drury PL, Rudge SR, Perrett D. Structural requirements for activity of certain ‘specific’ antirheumatic drugs: more than a simple thiol group? BrJ Rheumatol 1984;23:100-6.
13. Pullar T, Hunter JA, Capell HA. Which com ponent of sulphasalazine is active in rheumatoid arthritis? Br MedJ 1985;290:1535-8.
14. Neumann VC, Taggart AJ, Le Gallez P, Astb-ury C, Hill J, Bird HA. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 1986; 13: 285-7.
15. Dixon JS, Pickup ME, Lowe JR, Hallett J, Lee MR, Wright V. Discriminatory indices of response of patients with rheumatoid arthritis treated with D-penicillamine. Ann Rheum Dis 1980;39:301-11.
16. Dixon ASTJ, Davies J, Dormandy TL, et al. Synthetic d(-)penicillamine in rheumatoid arthritis: double-blind controlled study of a high and low dosage regimen. Ann Rheum Dis 1975;34:416-21.
17. Gibson T, Huskisson EC, Wojtulewski JA, et al. Evidence that D-penicillamine alters the course of rheumatoid arthritis. Rheumatol Rehabil 1976;15:211-5.
18. Berry H, Fernandes L, Ford-Hutchinson AW, Evans SJW, Hamilton EBD. Alclofenac and D-penicillamine—comparative trial in rheumatoid arthritis. Ann Rheum Dis 1978;37: 93-7.
19. Dixon JS, Bird HA, Pickup ME, Wright V. A human model system for the detection of specific antirheumatic activity. Semin Arthritis Rheum 1982;12:185-90.
20. Day RO, Graham GG, Champion GD, Lee E. Anti-rheumatic drug interactions. Clin Rheum Dis 1984;10:251-75.
21. Williams HJ, Ward JR, Reading JC, e/a/. Low- dose D-penicillamine therapy in rheumatoid arthritis. Arthritis Rheum 1983;26:581-92.
22. Nissila M, Nuotio P, von Essen R, Makisara P. Low-dose penicillamine treatment of rheu matoid arthritis: comparison of 600 mg and 300 mg regimens. Scand J Rheumatol 1982; 11:162-4.
23. Martin M, Sitton N, Dixon J, Hickling P, Golding J, Wright V. Penicillamine failures —what can be done? [Abstract]. British Association for Rheumatology and Rehabilitation and the Heberden Society, Combined meeting, Cambridge, September 1982.
24. McCarty DJ, Carrera GF. Intractable rheu matoid arthritis: treatment with combined cyclophosphamide, azathioprine and hydroxychloroquine. JAMA 1982;248:1718-23.
25. Neumann V, Hopkins R, Dixon J, Watkins A, Bird H, Wright V. Combined therapy with pulsed méthylprednisolone in rheumatoid arthritis. Ann Rheum Dis 1985;44:747-51.